Bet on these diagnostic stocks for up to 19% return as Covid-19 cases flare

Shares of diagnostics companies were in the spotlight on Monday in an otherwise feeble market as India reported its highest-ever daily tally of 1.03 lakh Covid-19 cases. According to the Union Health Ministry data, India recorded 1,03,558 coronavirus infections on Sunday, pushing the nationwide Covid tally to 1.25 crore.

Among individual stocks, Thyrocare Tech and Metropolis Healthcare rose over 4 per cent each, in intra-day deals, while Dr Lal PathLabs gained 3.9 per cent to hit a record high of Rs 2,924.85. In comparison, the benchmark S&P BSE Sensex was trading 2.6 per cent lower, at 11:30 AM. READ